HomeComparePETQ vs GBDC

PETQ vs GBDC: Dividend Comparison 2026

PETQ yields 6.46% · GBDC yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PETQ wins by $2.6K in total portfolio value
10 years
PETQ
PETQ
● Live price
6.46%
Share price
$30.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.6K
Annual income
$973.55
Full PETQ calculator →
GBDC
GBDC
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full GBDC calculator →

Portfolio growth — PETQ vs GBDC

📍 PETQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPETQGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PETQ + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PETQ pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PETQ
Annual income on $10K today (after 15% tax)
$548.74/yr
After 10yr DRIP, annual income (after tax)
$827.52/yr
GBDC
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, PETQ beats the other by $63.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PETQ + GBDC for your $10,000?

PETQ: 50%GBDC: 50%
100% GBDC50/50100% PETQ
Portfolio after 10yr
$29.3K
Annual income
$936.38/yr
Blended yield
3.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

PETQ
No analyst data
Price Target
$31.00
+0.1% upside vs current
Range: $31.00 — $31.00
Altman Z
2.5
Piotroski
8/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
-72.0% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PETQ buys
0
GBDC buys
0
No recent congressional trades found for PETQ or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPETQGBDC
Forward yield6.46%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$30.6K$28.0K
Annual income after 10y$973.55$899.19
Total dividends collected$8.1K$6.4K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst price target$31.00$14.00

Year-by-year: PETQ vs GBDC ($10,000, DRIP)

YearPETQ PortfolioPETQ Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,346$645.58$11,120$420.00+$226.00PETQ
2$12,824$684.53$12,357$458.31+$467.00PETQ
3$14,445$723.13$13,721$499.76+$724.00PETQ
4$16,218$761.23$15,227$544.58+$991.00PETQ
5$18,151$798.73$16,885$593.02+$1.3KPETQ
6$20,258$835.49$18,713$645.34+$1.5KPETQ
7$22,547$871.43$20,724$701.81+$1.8KPETQ
8$25,032$906.47$22,938$762.73+$2.1KPETQ
9$27,725$940.52$25,372$828.41+$2.4KPETQ
10$30,639$973.55$28,047$899.19+$2.6KPETQ

PETQ vs GBDC: Complete Analysis 2026

PETQStock

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

Full PETQ Calculator →

GBDCBDC

GBDC is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in GBDC shares.

Full GBDC Calculator →
📬

Get this PETQ vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PETQ vs SCHDPETQ vs JEPIPETQ vs OPETQ vs KOPETQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.